Nancy A. Jenkins, 2 George Kassiotis, 3 ‡ George Kollias, 3 Don W. Cleveland 1 † Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), a progressive paralytic disease characterized by loss of motor neurons. With the use of mice carrying a deletable mutant gene, expression within motor neurons was shown to be a primary determinant of disease onset and of an early phase of disease progression. Diminishing the mutant levels in microglia had little effect on the early disease phase but sharply slowed later disease progression. Onset and progression thus represent distinct disease phases defined by mutant action within different cell types to generate non-cell-autonomous killing of motor neurons; these findings validate therapies, including cell replacement, targeted to the non-neuronal cells.
A myotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease that selectively kills upper and lower motor neurons. Dominant mutations in the gene encoding the ubiquitously expressed superoxide dismutase (SOD1) are the most prominent known causes of inherited ALS (1) . Several hypotheses to explain motor neuron degeneration have been proposed, including mitochondrial dysfunction, protein aggregate formation, excitotoxicity, axonal transport malfunction, mutant-derived oxidative damage, lack of growth factors, and inflammation (2) . Ubiquitous expression of mutant SOD1 in rodents leads to a progressive selective degeneration of motor neurons because of an acquired toxic property or properties (3) (4) (5) . However, the contribution of damage mediated by mutant SOD1 to disease onset and progression in specific cell types of the spinal cord is not established. Expression of mutated SOD1 selectively in either motor neurons (6, 7) or astrocytes (8) has failed to cause ALS-like disease in mice. Although reducing SOD1 mutant accumulation within motor neurons by viral-delivered small interfering RNA can slow disease onset (9, 10), disease progression was not affected except in one case in which it was accelerated (10). Indeed, analyses of chimeric mice composed of mixtures of normal and SOD1 mutant-expressing cells have offered evidence that motor neuron death is non-cell-autonomous, with normal non-motor-neuronal cells having the ability to reduce or eliminate toxicity to mutant-expressing motor neurons (11) .
To identify which cell types are damaged by mutant SOD1 and how this damage might influence the initiation and propagation of the course of the disease, transgenic mice (LoxSOD1 G37R ) were generated that carried a mutant human SOD1 G37R gene flanked at both ends by 34-base pair LoxP sequences allowing recognition and regulated deletion by the Cre recombinase ( fig. S1A) (12) . Mice developed fatal progressive motor neuron disease, including progressive weight loss from denervation-induced muscle atrophy and paralysis that was essentially indistinguishable from that seen in previously described SOD1 G37R lines (5) . The LoxSOD1 G37R line with highest mutant accumulation reached end-stage disease most rapidly (between 8.5 and 11 months), which was accompanied by the death of 55% of spinal motor neurons ( fig. S1 , B to F) (12) . No human SOD1 protein was expressed in any progeny from the LoxSOD1 G37R females that also carried a transgene encoding the Cre recombinase in their (E) Total accumulated mutant SOD1 levels measured as relative total fluorescence intensity in motor axons from entire L5 roots in each animal (n 0 3 for each genotype). (F to H) Ages of (F) disease onset, (G) progression through an early disease phase (to 10% weight loss), and (H) disease end stage of (red) LoxSOD1 G37R /Isl1Cre þ mice and (blue) LoxSOD1 G37R littermates. Insets show ventral root motor axons (stained with toluidine blue) in LoxSOD1 G37R mice at (F) onset, (G) early disease, and (H) end stage. (I and J) Duration of (I) an early disease phase (from onset to 10% weight loss) and (J) a later disease phase (from 10% weight loss to end stage) for (red) LoxSOD1 G37R /Isl1Cre þ and (blue) LoxSOD1 G37R littermates. Scale bars in (A), (B), and (F) to (H), 50 mm.
oocytes (13) , demonstrating efficient in vivo gene removal in the presence of Cre (fig. S1, G and H) (12) .
To examine the contribution to the disease of mutant SOD1 toxicity within motor neurons, LoxSOD1 G37R mice were mated to mice carrying a Cre-encoding sequence under control of the promoter from the Islet-1 transcription factor (14) . Cre recombinase in this line is expressed in the nervous system exclusively in progenitors of motor and dorsal root ganglion neurons and was sufficient to substantially reduce mutant SOD1 accumulation in most motor axons of L5 motor roots and lumbar motor neurons of presymptomatic Isl1-Cre þ /LoxSOD1 G37R animals ( Fig. 1 , A to E, and fig. S2 ) (12) .
A simple objective measure of the earliest onset of disease was defined by the peak of the weight curve (12, 15) . This age coincides with initial axonal retraction from neuromuscular synapses but occurs before substantial axonal degeneration or loss proximally in motor roots emerging from the spinal cord ( Fig. 1F, inset ). An early stage of disease, accompanied by hindlimb weakness and obvious axonal degeneration (Fig. 1G, inset) , was defined to be the period from onset until denervation-induced muscle atrophy decreased maximal weight by 10%. Reduction of SOD1 G37R in motor neurons slowed disease onset in a minority of LoxSOD1 G37R /Isl1Cre (Fig. 1F) . Progression from onset through early disease was delayed in all of the mice, with a mean extension of 31 days (Isl1Cre (Fig. 1H) . Microglia are the resident immune cells of the central nervous system and are the primary mediators of neuroinflammation (16) . In the normal adult nervous system, these cells exist in a resting state and are characterized by a small cell body and fine ramified processes. However, neuronal damage can rapidly activate the release of cytotoxic and inflammatory mediators, including oxygen radicals, nitric oxide, and cytokines, that affect neighboring neurons and astrocytes (16, 17) ; in ALS, strong activation and proliferation of microglia occur in regions of motor neuron loss (18, 19) . Minocycline, an antibiotic that can inhibit microglial activation (20) , extends the survival of SOD1 mutant mice (21) (22) (23) , as does the inhibition of cyclooxygenase 2 (COX-2) (24), a key enzyme in prostaglandin synthesis. Both findings have raised the possibility of direct microglial involvement in ALS.
To test the role of the SOD1 mutant acting within microglia, we generated mice expressing Cre selectively in these cells using the promoter for CD11b (25) , an integrin expressed exclusively in the myeloid lineage (26) (fig. S3A ) (12) . Cell-type specificity of Cre expression was verified by mating those mice to the Rosa26 mouse line that ubiquitously expresses a b-galactosidase (b-Gal) transgene that can be translated into functional b-Gal only if Cremediated recombination removes a premature translation terminator (27) fig. S3, B and D to G) (12) . Although both neurons and astrocytes from Rosa26 mice showed high levels of b-Gal activity after germline Cre expression (Fig. 2B) , only small microglia-like cells expressed b-Gal in mice with the CD11b-encoded Cre and no b-Gal expression was detectable in neurons or astrocytes ( Fig. 2A) .
CD11b-Cre expression significantly diminished SOD1 G37R accumulation in peritoneal macrophages of LoxSOD1 G37R animals ( littermates and then cultured for 2 weeks, showed a 25% Cre-dependent decrease in the SOD1 G37R transgene levels (Fig. 2E) . A similar reduction in mutant SOD1 was seen in adult microglia (Fig. 2F) . Mutant SOD1 transgene content was unchanged in purified astrocytes (Fig. 2, G and H) . Microglial activation begins at or before disease onset in mutant SOD1 mice (21, 28, 29) , with the number of activated cells escalating during progression, as measured with antibodies to CD11b or Iba1 (Fig. 3, A to C) . No differences in microglia (Fig. 3, D to F) or astrocyte (Fig. 3 , G to I) activation were observed in disease-matched LoxSOD1 G37R /CD11b-Cre þ and LoxSOD1 G37R mice. Nevertheless, lowering mutant SOD1 expression within microglia significantly extended the survival of LoxSOD1 G37R mice, with a longer mean survival of 99 days relative to the cohort of LoxSOD1 G37R littermates (Fig. 3J) . Half of the Cre-expressing cohort survived more than 100 days past the mean survival of LoxSOD1 G37R mice, and most of this extension was derived from slowing disease progression after onset. Indeed, although early disease progression was unchanged (Fig. 3K) , the progression of later disease in CD11b-Cre þ mice was slowed by an average of 75 days (Fig. 3L) . This slowing of later disease may derive in part from gene inactivation not just in microglia but also in peripheral macrophages or their progenitors and/or from the migration of those cells into the central nervous system after initial damage to motor neurons.
The potential for different mechanisms underlying disease initiation and progression has previously been proposed in human ALS from observations of disease spread from an initially affected region. Our use of partial, selective gene inactivation offers direct evidence for mutant SOD1 damage within different cell types to underlie an initiating phase of disease caused by mutant SOD1 damage within motor neurons, and a mechanistically divergent later phase encompassing the progression to complete paralysis that is linked to the inflammatory response of microglia and mutant toxicity within these cells. These findings have important implications for the development of successful therapies for mutant SOD1-mediated as well as sporadic ALS. Although the mechanistic linkage between familial and sporadic ALS has not been unambiguously established, the two forms of disease are clinically indistinguishable, affect the same neurons, are characterized by ubiquitinated aggregates as hallmarks, display a loss of astrocytic glutamate transporters, and are accompanied by microgliosis and astrocytosis (2) . In our study, limiting mutant damage to microglia robustly slowed the disease_s course, even when all motor neurons were expressing high levels of a SOD1 mutant. Thus, although the initiation of the disease requires damage to motor neurons and probably to additional cell types, disease therapy might be successful by targeting only a single non-neuronal cell type. Loss of seed shattering was a key event in the domestication of major cereals. We revealed that the qSH1 gene, a major quantitative trait locus of seed shattering in rice, encodes a BEL1-type homeobox gene and demonstrated that a single-nucleotide polymorphism (SNP) in the 5 ¶ regulatory region of the qSH1 gene caused loss of seed shattering owing to the absence of abscission layer formation. Haplotype analysis and association analysis in various rice collections revealed that the SNP was highly associated with shattering among japonica subspecies of rice, implying that it was a target of artificial selection during rice domestication.
C ultivation of major cereals likely started about 10,000 years ago (1) (2) (3) (4) . During this domestication, ancient humans subjected several key events to selection. These included increase in the number of seeds, improvement of fertility, change in plant architecture, change in seed shape, adaptation of flowering time to local areas, loss of seed color, and loss of seed shattering.
Recent studies in rice have revealed that several independent domestication events might have occurred to establish cultivated rice (3, (5) (6) (7) . The archaeological record reveals that japonica rice, a subspecies of Oryza sativa, was bred about 10,000 years ago in the upstream regions of the Yangtze River in southwest China (3, 8, 9) .
The loss of seed-shattering habit is thought to be one of the most important events in rice domestication, because the Beasy-to-shatter[ trait in wild relatives results in severe reduction in yield. Over the course of human history, distinct grain-threshing systems have been developed in several different eras in local areas of the world, in accordance with the degree of seed shattering. In current ricebreeding programs, this seed-shattering habit is still a target, especially in the construction of new indica (another subspecies of O. sativa) cultivars. Thus, seed-shattering habit is one of 
